Medsender secured a $5 million Series A investment from Ballast Point Ventures to enhance its AI-driven workflow automation platform for healthcare providers.
Information on the Target
Medsender is an innovative AI-powered workflow automation platform designed specifically for healthcare providers. With its robust capabilities, Medsender is trusted by thousands of healthcare organizations across all fifty states to alleviate administrative burdens significantly. The platform harnesses artificial intelligence to process and synchronize data from unstructured sources such as faxes, emails, and phone calls, effectively automating various administrative workflows and enhancing patient communications.
Notably, Medsender allows healthcare providers to streamline operations by automating complex processes such as referral processing, patient scheduling, and request management. This technology enables providers to concentrate on delivering high-quality care, rather than getting bogged down by administrative tasks. Medsender's integration with MAIRA™, a human-like AI phone agent, can reduce call-handling times by as much as 80%, contributing to an overall enhanced operational efficiency.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the United States
The healthcare industry in the United States is currently undergoing a significant transformation driven by technological advancements and an increased demand for operational efficiency. As healthcare providers look for ways to improve patient care while man
Similar Deals
Broadview Ventures and Advent Life Sciences → Relief Cardiovascular
2025
SPRIM Global Investments and William Taylor Nominees → RheumaGen, Inc.
2025
New Markets Venture Partners → FamilyWell Health
2025
Treo Ventures → SecondWave Systems, Inc.
2025
Five Elms Capital → Motivity
2025
Ballast Point Ventures
invested in
Medsender
in 2025
in a Series A deal
Disclosed details
Transaction Size: $5M